Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2Sarcoma 1Plasma cell 1Myeloid 1

Conditions

Melanoma 63Leukemia, Myeloid, Acute 31Leukemia 25Carcinoma, Renal Cell 23Lymphoma 21Kidney Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Neoplasm Metastasis 14Lymphoma, Mantle-Cell 13Myelodysplastic Syndromes 12Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Leukemia, Lymphocytic, Chronic, B-Cell 12Neuroblastoma 11Ovarian Neoplasms 10Congenital Abnormalities 10Lymphoma, B-Cell, Marginal Zone 9Breast Neoplasms 9Multiple Myeloma 8Hodgkin Disease 8Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 7Recurrence 7Lymphoma, Large B-Cell, Diffuse 7Burkitt Lymphoma 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Skin Neoplasms 5Pancreatic Neoplasms 5Myeloproliferative Disorders 5

Interventions

Cyclophosphamide 54Tacrolimus 50Methotrexate 36Mycophenolic Acid 34fludarabine phosphate 33Busulfan 31Cyclosporine 29fludarabine 28Antilymphocyte Serum 28Melphalan 23Sirolimus 21Whole-Body Irradiation 18Radiotherapy 18Peripheral Blood Stem Cell Transplantation 18Methylprednisolone 18Filgrastim 15thymoglobulin 13Thiotepa 10Stem Cell Transplantation 9Rituximab 9Granulocyte Colony-Stimulating Factor 8Hematopoietic Stem Cell Transplantation 7Etoposide 7Cord Blood Stem Cell Transplantation 7Cytarabine 6Alemtuzumab 6ruxolitinib 5Transplantation 5Therapeutics 5Prednisone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Graft vs Host Disease × aldesleukin × Clear all
NCT01390402 2016-02-03

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

M.D. Anderson Cancer Center

Phase 2 Completed
6 enrolled 3 charts
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00003414 2015-07-20

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 3 Completed
50 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT00248430 2010-09-21

Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡